-
Junshi Biosciences Announces the Completion of First Patient Dosing in the Phase 3 Clinical Trial of Junshi Biosciences Announces the Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS207 in Combination with JS007 for the First-Line Treatment of Advanced Hepatocellular Carcinoma ...资讯2026-10-29
最热
推荐
- Dentsu Appoints Shirli Zelcer to Chief Data and Technology Officer
- Bitget Wallet Launches New Brand Identity and "Crypto for Everyone" Movement
- 眼球保留与义眼:重拾视觉,重塑生活
- 中远海运港口公布2026年第三季度业绩
- 平安健康与诺和诺德战略携手,共筑科学减重服务闭环
- 中能拾贝CyberwIBD:筑牢能源电力行业“数据底座”,构建数据智能新生态
- 中能国宏协办丨第三届“保险杯”AI电力交易大赛研讨会暨颁奖活动在西安圆满落幕
- 泰德阳光综合成品支架助力青海联通三江源数据中心——穿透式安全支架与BIM技术共筑绿色算力新标杆
- 电子制造产业联盟屹博杯全国电子制造行业技能大赛顺利举办
- 以赛促学竞风采——农发行郴州市分行举办学习宣传贯彻党的二十届三中全会精神知识竞赛侧记
